Examples of Meeting Topics


A list of meetings held in 2006 will be found here.

The Center holds workshop-discussion style meetings on topics in almost every area of modern experimental biology and on important policy issues. Typically, subject areas may be very new and in need of assessment; they may be well-established but in need to critical review to examine where the best leads are; or controversial so that the meeting brings the warring parties together on neutral ground. Whatever the topic, we try to have an interesting mix of participants who would not normally meet. Meetings generally have some policy aspect to them and several major initiatives can be traced to discussions held at Banbury.

The Center concentrated initially on controversial topics relating to carcinogenesis and environmental hazards. For example, there were meetings on:


There was an early interest in molecular biology and genetics, in part because of Cold Spring Harbor Laboratory's historic association with genetics. An early example was Enhancers and Controlling Elements held in 1983. Other examples include:

Conference in progress

Human genetics has played a key role in the Center's activities, with a very early discussion of linkage analysis using restriction fragment polymorphisms at the Recombinant DNA Applications to Human Disease meeting in 1982.

The human genetic meetings have also discussed the implications of advances in molecular human genetics for society:

From the beginnings of the Center's activites, there has been a strong emphasis on technical aspects of recombinant DNA technology and its applications in biotechnology:

The Center also specializes in meetings that involve both scientific research and policy. These meetings typically review current research and the mechanisms by which it is funded, and include scientists as well as individuals from relevant agencies. There have been such meetings on:

There are also meetings dealing almost exclusively with policy issues, including historic meetings on:

There have also been special meetings each year that discuss important scientific topics for science journalists, Congressional staff, and senior executives of pharmaceutical and biotechnology companies.